SAFETY AND EFFECTIVENESS OF PEMETREXED IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN JAPAN BASED ON POST-MARKETING SURVEILLANCE

被引：0
|
作者：
Okubo, Sumiko [1 ]
Kobayashi, Noriko [1 ]
Taketsuna, Masanori [1 ]
Enatsu, Sotaro [1 ]
Nishiuma, Shinichi [1 ]
机构：
[1] Eli Lilly Japan, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 11期
关键词：
Post-Marketing Surveillance; NSCLC; Pemetrexed;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-011
引用
收藏
页码：S485 / S485
页数：1
相关论文
共 50 条
  • [1] Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
    Sharareh Seifi
    Babak Salimi
    Zahra Esfahani Monfared
    Cyrus Sabahi
    Hamidreza Kafi
    Adnan Khosravi
    Journal of Pharmaceutical Policy and Practice, 16
  • [2] Alvopem® (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance
    Seifi, Sharareh
    Salimi, Babak
    Monfared, Zahra Esfahani
    Sabahi, Cyrus
    Kafi, Hamidreza
    Khosravi, Adnan
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [3] Real-world outcomes of pembrolizumab monotherapy in non-small cell lung cancer in Japan: A post-marketing surveillance
    Yamamoto, Nobuyuki
    Kamitani, Tetsu
    Kanda, Kingo
    Ito, Yuichiro
    Hamada, Masahiro
    Ozaki, Masahiko
    Takeuchi, Noriko
    Yamada, Tomoko
    Kawano, Masaki
    Maekawa, Shinichiroh
    Kato, Terufumi
    CANCER SCIENCE, 2022, 113 (09) : 3110 - 3119
  • [4] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    CHEMOTHERAPY, 2007, 53 (02) : 85 - 103
  • [5] Safety and Effectiveness of Gemcitabine in 260 Patients with Biliary Tract Cancer in a Japanese Clinical Practice Based on Post-marketing Surveillance in Japan
    Okubo, Sumiko
    Nishiuma, Shinichi
    Kobayashi, Noriko
    Taketsuna, Masanori
    Taniai, Hisashi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (11) : 1043 - 1053
  • [6] Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
    Kawasaki, Akira
    Hatake, Kiyohiko
    Matsumura, Itaru
    Izutsu, Koji
    Hoshino, Tomohiro
    Akamatsu, Ayumi
    Kakuuchi, Akito
    Tobinai, Kensei
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (06) : 667 - 676
  • [7] Post-marketing surveillance of the safety and effectiveness of naldemedine in the management of opioid-induced constipation in patients with cancer pain in Japan
    Keiko Takata
    Masami Nakazawa
    Keiichi Honda
    Sayo Hashimoto
    Supportive Care in Cancer, 2022, 30 : 3943 - 3954
  • [8] Post-marketing surveillance of the safety and effectiveness of naldemedine in the management of opioid-induced constipation in patients with cancer pain in Japan
    Takata, Keiko
    Nakazawa, Masami
    Honda, Keiichi
    Hashimoto, Sayo
    SUPPORTIVE CARE IN CANCER, 2022, 30 (05) : 3943 - 3954
  • [9] Pemetrexed-related interstitial lung disease reported from post marketing surveillance (malignant pleural mesothelioma/non-small cell lung cancer)
    Tomii, Keisuke
    Kato, Terufumi
    Takahashi, Masashi
    Noma, Satoshi
    Kobashi, Yoichiro
    Enatsu, Sotaro
    Okubo, Sumiko
    Kobayashi, Noriko
    Kudoh, Shoji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (04) : 350 - 356
  • [10] Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan
    Saida T.
    Yokoyama K.
    Sato R.
    Makioka H.
    Iizuka Y.
    Hase M.
    Ling Y.
    Torii S.
    Neurology and Therapy, 2017, 6 (2) : 197 - 211
12345